Nonoperative Treatment of Acute Achilles Tendor Rupture (NoArc)

February 12, 2024 updated by: Central Finland Hospital District

Nonoperative Treatment of Acute Achilles Tendor Rupture in Central Finland: Prospective Cohort Study

A prospective, non-randomised, observational study to investigate the clinical and biomechanical outcomes and prevalence of reruptures after operative or nonoperative treatment of acute achilles tendon rupture.

Study Overview

Status

Active, not recruiting

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Aleksi Reito, MD, PhD
  • Phone Number: +358142693119
  • Email: aleksi@reito.fi

Study Locations

    • Keski-Suomi
      • Jyväskylä, Keski-Suomi, Finland, 40620
        • Central Finland Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All patients having sustained an acute achilles tendon rupture and referred for either operative or nonoperative treatment with functional rehabilitation at our institution.

Description

Inclusion Criteria:

  • acute achilles tendon rupture with clear onset of symptoms
  • closed rupture
  • resides in the catchment area of our hospital district

Exclusion Criteria:

  • avulsion fractures in the calcaneus
  • unwillingness to participate
  • inability to communicate using Finnish language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Operative treatment
Patients having undergone an operative treatment of achilles tendon rupture
Open surgical repair of tendon rupture
Nonoperative treatment
Patients having undergone a nonoperative treatment with functional rehabilitation of achilles tendon rupture
Nonoperative treatment with lower leg orthosis and functional rehabilitation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rerupture rate
Time Frame: 1 year
Rate rerupture of a healed tendon after the end of the intervention
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Activity Level
Time Frame: 1 year
Patient activity 1 year after the rupture using the Tegner activity level scale which varies from 0 to 10. This scale that aims to provide a standardized method of grading work and sporting activities.
1 year
University of California, Los Angeles (UCLA) score
Time Frame: 1 year
Patient activity 1 year after the rupture
1 year
Achilles tendon rupture score (ATRS)
Time Frame: 1 year
Achilles tendon rupture score 1 year after the rupture
1 year
Functional Score
Time Frame: 1 year
Leppilahti score measuring subjective and objective functional outcome 1 year after the rupture on a scale 0-100.
1 year
Foot inversion
Time Frame: 1 year
Foot inversion angle in rest
1 year
Foot flexion-extension
Time Frame: 1 year
Foot flexion-extension angle in rest
1 year
Heel-raise test
Time Frame: 1 year
One leg heel-raise test while standing
1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle strength
Time Frame: 1 year
Isometric plantar flexion strength
1 year
Gastrocnemius muscle cross-sectional area
Time Frame: 1 year
Lateral and medial gastrocnemius and soleus muscle area using ultrasound
1 year
Tendon length
Time Frame: 1 year
Achilles tendon length using ultrasound
1 year
Research ANd Development (RAND-36) quality of life
Time Frame: 1 year
Measurement of quality of life using RAND-36 questionnaire
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Juha Paloneva, MD, PhD, Central Finland Health Care District

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2017

Primary Completion (Estimated)

August 31, 2024

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

October 10, 2018

First Submitted That Met QC Criteria

October 10, 2018

First Posted (Actual)

October 12, 2018

Study Record Updates

Last Update Posted (Estimated)

February 13, 2024

Last Update Submitted That Met QC Criteria

February 12, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Achilles Tendon Rupture

Clinical Trials on Operative treatment

3
Subscribe